NCT02805166 2016-06-17PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving ChemotherapyCSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Phase 4 Completed420 enrolled
NCT00516438 2010-12-08Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With TopotecanAstraZenecaPhase 1 Completed48 enrolled